No drugs are officially approved for borderline personality disorder, yet prescribing is widespread. This systematic review ...

Despite psychedelics’ roots in Indigenous and minoritised communities, clinical trials overwhelmingly centre White ...

Despite psychedelics’ deep ties with queer culture, research often excludes queer voices. This recent scoping review ...

A big new study suggests that certain genetic traits—like insomnia risk and neuroticism—may make depression harder to treat, ...

Informal coercion – the subtle pressure patients feel in psychiatric care – is common but poorly understood. A new scoping ...

MRC-funded PhD candidate at the MRC Integrative Epidemiology Unit, researching the causal association between inflammation ...

Nervousness, irritability, excessive worry, uncontrollable worry… not all anxiety symptoms weigh the same at different ages. This new Chineses study shows how anxiety networks tighten as young people ...

Women with ADHD are up to 4 times more likely to experience severe premenstrual mood symptoms than those without ADHD, especially if they also live with depression or anxiety. This new UK study shines ...

Charnele Nunes is the Social Care Elf Coordinator for the National Elf Service, in the Care Policy and Evaluation Centre (CPEC) at the London School of Economics and Political Science (LSE). She is ...

Suicide remains a critical global public health issue, significantly contributing to disability and mortality worldwide. Each year, more than 700,000 individuals die by suicide, with an estimated 25 ...

Novel psychoactive substances (NPS; also known as new psychoactive substances or popularly, although erroneously, as ‘legal highs’) is the name given to drugs that are newly synthesised or newly ...

Trigger warnings are used to help individuals avoid or emotionally prepare for content that may cause them emotional or psychological distress (Cares et al., 2019; DeBonis, 2019; George & Hovey, 2020) ...